ES2126308T3 - Sistema terapeutico percutaneo a base de estradiol con aditivos hidrofilos. - Google Patents

Sistema terapeutico percutaneo a base de estradiol con aditivos hidrofilos.

Info

Publication number
ES2126308T3
ES2126308T3 ES95929104T ES95929104T ES2126308T3 ES 2126308 T3 ES2126308 T3 ES 2126308T3 ES 95929104 T ES95929104 T ES 95929104T ES 95929104 T ES95929104 T ES 95929104T ES 2126308 T3 ES2126308 T3 ES 2126308T3
Authority
ES
Spain
Prior art keywords
estradiol
therapeutic system
system based
hydrophilic additives
percutaneous therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95929104T
Other languages
English (en)
Inventor
Michael Horstmann
Walter Muller
Hanshermann Franke
Thomas Pontzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2126308T3 publication Critical patent/ES2126308T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Auxiliary Drives, Propulsion Controls, And Safety Devices (AREA)
  • Traffic Control Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SISTEMA TERAPEUTICO SUBCUTANEO CON ESTRADIOL COMO PRINCIPIO ACTIVO Y OPCIONALMENTE CON OTROS PRINCIPIOS ACTIVOS Y CON UN ADITIVO HIDROFILICO, CON UNA ESTRUCTURA ESTRATIFICADA COMPRENDIENDO UN SOPORTE QUE ES IMPERMEABLE AL PRINCIPIO ACTIVO Y A LA HUMEDAD, UNA CAPA MATRIZ QUE CONTIENE EL PRINCIPIO ACTIVO, Y OPCIONALMENTE UNA CAPA DE PROTECCION SEPARABLE; SE CARACTERIZA PORQUE EL ADITIVO HIGROSCOPICO ES UN COMPONENTE DE LA MATRIZ.
ES95929104T 1994-08-20 1995-08-12 Sistema terapeutico percutaneo a base de estradiol con aditivos hidrofilos. Expired - Lifetime ES2126308T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4429664A DE4429664C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ES2126308T3 true ES2126308T3 (es) 1999-03-16

Family

ID=6526229

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95929104T Expired - Lifetime ES2126308T3 (es) 1994-08-20 1995-08-12 Sistema terapeutico percutaneo a base de estradiol con aditivos hidrofilos.

Country Status (21)

Country Link
EP (1) EP0776197B1 (es)
JP (1) JPH10504314A (es)
KR (1) KR100374476B1 (es)
CN (1) CN1073413C (es)
AT (1) ATE173163T1 (es)
AU (1) AU700119B2 (es)
CA (1) CA2197865C (es)
CZ (1) CZ50897A3 (es)
DE (2) DE4429664C2 (es)
DK (1) DK0776197T3 (es)
ES (1) ES2126308T3 (es)
FI (1) FI118721B (es)
HU (1) HUT77093A (es)
IL (1) IL114948A (es)
NO (1) NO970553L (es)
NZ (1) NZ291449A (es)
PL (1) PL180943B1 (es)
SI (1) SI0776197T1 (es)
SK (1) SK280299B6 (es)
WO (1) WO1996005815A1 (es)
ZA (1) ZA956926B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
DE4223360C1 (es) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (es) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut

Also Published As

Publication number Publication date
WO1996005815A1 (de) 1996-02-29
NO970553D0 (no) 1997-02-06
DK0776197T3 (da) 1999-07-26
KR970705380A (ko) 1997-10-09
EP0776197A1 (de) 1997-06-04
IL114948A (en) 2000-10-31
CZ50897A3 (en) 1997-06-11
DE4429664A1 (de) 1996-02-22
ATE173163T1 (de) 1998-11-15
KR100374476B1 (ko) 2003-04-23
NO970553L (no) 1997-02-06
CA2197865A1 (en) 1996-02-29
DE59504233D1 (de) 1998-12-17
NZ291449A (en) 1998-09-24
CA2197865C (en) 2005-10-25
MX9701301A (es) 1998-05-31
CN1155836A (zh) 1997-07-30
EP0776197B1 (de) 1998-11-11
FI970702A0 (fi) 1997-02-19
FI970702L (fi) 1997-02-19
FI118721B (fi) 2008-02-29
AU700119B2 (en) 1998-12-24
PL319014A1 (en) 1997-07-21
DE4429664C2 (de) 1997-09-11
SK280299B6 (sk) 1999-11-08
AU3258395A (en) 1996-03-14
JPH10504314A (ja) 1998-04-28
SK21997A3 (en) 1997-07-09
SI0776197T1 (en) 1999-04-30
IL114948A0 (en) 1995-12-08
HUT77093A (hu) 1998-03-02
ZA956926B (en) 1996-03-25
CN1073413C (zh) 2001-10-24
PL180943B1 (pl) 2001-05-31

Similar Documents

Publication Publication Date Title
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ATE306254T1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
IS6344A (is) Lyfjasamsetningar sem leiða til aukinna lyfjastyrkja
ATE244558T1 (de) Trockene formbare arzneistoffformulierung
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
EP0177893A3 (en) Sustained release dosage form based on highly plasticized cellulose ether gels
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
TW570815B (en) Transdermal therapeutic system (TTS) containing the active substance fentanyl
FI83390B (fi) Foerfarande foer framstaellning av ett medel foer transdermal administration av i vatten svaorloesliga laekemedel.
ATE89819T1 (de) Gegebenenfalls alpha-substituierte 4-(chinolin-2- yl-methoxy)phenylessigsaeuren und -ester.
NO307644B1 (no) Transdermalt, terapeutisk system med krystalliseringsinhibitor
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
ES2032905T3 (es) Sistema terapeutico transcutaneo.
DK1069892T3 (da) Fugtighedsaktiverbart terapeutisk system
ES2116572T3 (es) Parche para la administracion percutanea de sustancias de contenido quimicamente basico, farmaceuticamente eficaces y volatiles, y un metodo para su fabricacion.
DK324687A (da) Transdermalt farmeceutisk praeparat
YU14394A (sh) Flaster sa aktivnom supstancom za davanje estradiola na kožu
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2126308T3 (es) Sistema terapeutico percutaneo a base de estradiol con aditivos hidrofilos.
MY112477A (en) Scopolamine patch
AU2108300A (en) Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids
ES2139932T3 (es) Sistema terapeutico percutaneo a base de estradiol con aditivos higroscopicos.
ES2087407T3 (es) Derivados de cromano sustituido con piperidilmetilo como principio activo para el tratamiento de enfermedades del sistema nervioso central.
ATE109980T1 (de) Transdermale absorbierbare eperison- oder tolperison-arzneizubereitung.
ES2164777T3 (es) Sistema terapeutico transdermal con proteccion contra la hidrolisis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 776197

Country of ref document: ES